Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe pre-eclampsia.

Maia SB, Katz L, Neto CN, Caiado BV, Azevedo AP, Amorim MM.

Int J Gynaecol Obstet. 2014 Sep;126(3):260-4. doi: 10.1016/j.ijgo.2014.03.024. Epub 2014 May 10.

PMID:
24890747
2.
3.

A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy.

Fontenot MT, Lewis DF, Frederick JB, Wang Y, DeFranco EA, Groome LJ, Evans AT.

Am J Obstet Gynecol. 2005 Jun;192(6):1788-93; discussion 1793-4.

PMID:
15970809
4.

A shortened postpartum magnesium sulfate prophylaxis regime in pre-eclamptic women at low risk of eclampsia.

Darngawn L, Jose R, Regi A, Bansal R, Jeyaseelan L.

Int J Gynaecol Obstet. 2012 Mar;116(3):237-9. doi: 10.1016/j.ijgo.2011.09.028. Epub 2012 Jan 18.

PMID:
22261127
5.
6.

The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period.

Vigil-De Gracia P, Ludmir J.

J Matern Fetal Neonatal Med. 2015;28(18):2207-9. doi: 10.3109/14767058.2014.982529. Epub 2014 Nov 27. Review.

PMID:
25373431
7.

Individually determined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia.

Ascarelli MH, Johnson V, May WL, Martin RW, Martin JN Jr.

Am J Obstet Gynecol. 1998 Oct;179(4):952-6.

PMID:
9790377
8.
9.
10.

Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial.

Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM.

Obstet Gynecol. 2003 Feb;101(2):217-20.

PMID:
12576241
11.
12.

Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy.

Isler CM, Barrilleaux PS, Rinehart BK, Magann EF, Martin JN Jr.

Obstet Gynecol. 2003 Jan;101(1):66-9.

PMID:
12517647
13.

Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.

Salinger DH, Mundle S, Regi A, Bracken H, Winikoff B, Vicini P, Easterling T.

BJOG. 2013 Jun;120(7):894-900. doi: 10.1111/1471-0528.12222. Epub 2013 Mar 26.

14.

Prostacyclin and thromboxane levels in women with severe preeclampsia undergoing magnesium sulfate therapy during antepartum and postpartum periods.

Wang Y, Zhang Y, Canzoneri BJ, Gu Y, Philibert L, Lewis DF.

Hypertens Pregnancy. 2008;27(1):17-27. doi: 10.1080/10641950701825721.

15.

Use of parenteral magnesium sulphate in eclampsia and severe pre-eclampsia cases in a rural set up of Bangladesh.

Shamsuddin L, Nahar K, Nasrin B, Nahar S, Tamanna S, Kabir RM, Alis MJ, Anwary SA.

Bangladesh Med Res Counc Bull. 2005 Aug;31(2):75-82.

PMID:
16967813
16.

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.

Belfort MA, Anthony J, Saade GR, Allen JC Jr; Nimodipine Study Group.

N Engl J Med. 2003 Jan 23;348(4):304-11.

17.

Ionized and total magnesium concentration in patients with severe pre-eclampsia-eclampsia undergoing magnesium sulfate therapy.

Mahajan NN.

J Obstet Gynaecol Res. 2008 Feb;34(1):126, author reply 128. doi: 10.1111/j.1447-0756.2007.00717.x. No abstract available.

PMID:
18226146
18.

Magnesium sulfate therapy in preeclampsia and eclampsia.

Witlin AG, Sibai BM.

Obstet Gynecol. 1998 Nov;92(5):883-9. Review.

PMID:
9794688
19.

Neonatal effects of magnesium sulfate given to the mother.

Abbassi-Ghanavati M, Alexander JM, McIntire DD, Savani RC, Leveno KJ.

Am J Perinatol. 2012 Nov;29(10):795-9. doi: 10.1055/s-0032-1316440. Epub 2012 Jul 6.

PMID:
22773290
20.

A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.

McDonald SD, Lutsiv O, Dzaja N, Duley L.

Int J Gynaecol Obstet. 2012 Aug;118(2):90-6. doi: 10.1016/j.ijgo.2012.01.028. Epub 2012 Jun 15. Review.

PMID:
22703834
Items per page

Supplemental Content

Write to the Help Desk